Subscribe to RSS
DOI: 10.1055/s-0028-1087168
© Georg Thieme Verlag KG Stuttgart · New York
Sex- and Depot-specific Lipolysis Regulation in Human Adipocytes: Interplay between Adrenergic Stimulation and Glucocorticoids
Publication History
received 14.01.2008
accepted 23.06.2008
Publication Date:
25 September 2008 (online)
Abstract
The purpose of this investigation was to explore interactions between adrenergic stimulation, glucocorticoids, and insulin on the lipolytic rate in isolated human adipocytes from subcutaneous and omental fat depots, and to address possible sex differences. Fat biopsies were obtained from 48 nondiabetic subjects undergoing elective abdominal surgery. Lipolysis rate was measured as glycerol release from isolated cells and proteins involved in lipolysis regulation were assessed by immunoblots. Fasting blood samples were obtained and metabolic and inflammatory variables were analyzed. In women, the rate of 8-bromo-cAMP- and isoprenaline-stimulated lipolysis was ∼2- and 1.5-fold higher, respectively, in subcutaneous compared to omental adipocytes, whereas there was no difference between the two depots in men. Dexamethasone treatment increased the ability of 8-bromo-cAMP to stimulate lipolysis in the subcutaneous depot in women, but had no consistent effects in fat cells from men. Protein kinase A, Perilipin A, and hormone sensitive lipase content in adipocytes was not affected by adipose depot, sex, or glucocorticoid treatment. In conclusion, catecholamine and glucocorticoid regulation of lipolysis in isolated human adipocytes differs between adipose tissue depots and also between sexes. These findings may be of relevance for the interaction between endogenous stress hormones and adipose tissue function in visceral adiposity and the metabolic syndrome.
Key words
visceral - subcutaneous - adipose tissue - cAMP - dexamethasone
References
- 1 Kissebah AH, Krakower GR. Regional adiposity and morbidity. Physiol Rev. 1994; 74 761-811
- 2 Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000; 21 697-738
- 3 Jensen MD. Adipose tissue metabolism – an aspect we should not neglect?. Horm Metab Res. 2007; 39 722-725
- 4 Degerman E, Belfrage P, Manganiello VC. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem. 1997; 272 6823-6826
- 5 Bolinder J, Kager L, Ostman J, Arner P. Differences at the receptor and postreceptor levels between human omental and subcutaneous adipose tissue in the action of insulin on lipolysis. Diabetes. 1983; 32 117-123
- 6 Hoffstedt J, Arner P, Hellers G, Lonnqvist F. Variation in adrenergic regulation of lipolysis between omental and subcutaneous adipocytes from obese and non-obese men. J Lipid Res. 1997; 38 795-804
- 7 Ostman J, Arner P, Engfeldt P, Kager L. Regional differences in the control of lipolysis in human adipose tissue. Metabolism. 1979; 28 1198-1205
- 8 Svedberg J, Bjorntorp P, Smith U, Lonnroth P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes. 1990; 39 570-574
- 9 Jensen MD, Cardin S, Edgerton D, Cherrington A. Splanchnic free fatty acid kinetics. Am J Physiol Endocrinol Metab. 2003; 284 E1140-E1148
- 10 Boden G, Jadali F. Effects of lipid on basal carbohydrate metabolism in normal men. Diabetes. 1991; 40 686-692
- 11 Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI. Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 1996; 97 2859-2865
- 12 Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P, Dall’omo AM, Imbimbo B. An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest. 1983; 72 1814-1820
- 13 Lonn L, Kvist H, Ernest I, Sjostrom L. Changes in body composition and adipose tissue distribution after treatment of women with Cushing's syndrome. Metabolism. 1994; 43 1517-1522
- 14 Wesslau C, Eriksson JW, Smith U. Cellular cyclic AMP levels modulate insulin sensitivity and responsiveness–evidence against a significant role of Gi in insulin signal transduction. Biochem Biophys Res Commun. 1993; 196 287-293
- 15 Lonnqvist F, Nyberg B, Wahrenberg H, Arner P. Catecholamine-induced lipolysis in adipose tissue of the elderly. J Clin Invest. 1990; 85 1614-1621
- 16 Lundgren M, Buren J, Ruge T, Myrnas T, Eriksson JW. Glucocorticoids down-regulate glucose uptake capacity and insulin-signaling proteins in omental but not subcutaneous human adipocytes. J Clin Endocrinol Metab. 2004; 89 2989-2997
- 17 Lukaski HC, Bolonchuk WW, Hall CB, Siders WA. Validation of tetrapolar bioelectrical impedance method to assess human body composition. J Appl Physiol. 1986; 60 1327-1332
- 18 Smith U, Sjostrom L, Bjornstorp P. Comparison of two methods for determining human adipose cell size. J Lipid Res. 1972; 13 822-824
- 19 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28 412-419
- 20 Allen DO. Rate-limiting steps in isoproterenol and forskolin stimulated lipolysis, Biochemical pharmacology. 1985; 34 843-846
- 21 Kashiwagi A, Bogardus C, Lillioja S, Huecksteadt TP, Brady D, Verso MA, Foley JE. In vitro insensitivity of glucose transport and antilipolysis to insulin due to receptor and postreceptor abnormalities in obese Pima Indians with normal glucose tolerance. Metabolism. 1984; 33 772-777
- 22 Rebuffe-Scrive M, Andersson B, Olbe L, Bjorntorp P. Metabolism of adipose tissue in intraabdominal depots of nonobese men and women. Metabolism. 1989; 38 453-458
- 23 Bjorntorp P. Metabolic implications of body fat distribution. Diabetes Care. 1991; 14 1132-1143
- 24 Pedersen SB, Kristensen K, Hermann PA, Katzenellenbogen JA, Richelsen B. Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution. J Clin Endocrinol Metab. 2004; 89 1869-1878
- 25 Dicker A, Ryden M, Näslund E Muehlen IE, Wiren M, Lafontan M, Arner P. Effect of testosterone on lipolysis in human pre-adipocytes from different fat depots. Diabetologia. 2004; 47 420-428
- 26 Tchernof A, Belanger C, Morisset AS, Richard C, Mailloux J, Laberge P, Dupont P. Regional differences in adipose tissue metabolism in women: minor effect of obesity and body fat distribution. Diabetes. 2006; 55 1353-1360
- 27 Kolehmainen M, Vidal H, Ohisalo JJ, Pirinen E, Alhava E, Uusitupa MI. Hormone sensitive lipase expression and adipose tissue metabolism show gender difference in obese subjects after weight loss. Int J Obes Relat Metab Disord. 2002; 26 6-16
- 28 Large V, Arner P, Reynisdottir S, Grober J, Harmelen V Van, Holm C, Langin D. Hormone-sensitive lipase expression and activity in relation to lipolysis in human fat cells. J Lipid Res. 1998; 39 1688-1695
- 29 Divertie GD, Jensen MD, Miles JM. Stimulation of lipolysis in humans by physiological hypercortisolemia. Diabetes. 1991; 40 1228-1232
- 30 Gravholt CH, Dall R, Christiansen JS, Moller N, Schmitz O. Preferential stimulation of abdominal subcutaneous lipolysis after prednisolone exposure in humans. Obes Res. 2002; 10 774-781
- 31 Krsek M, Rosicka M, Nedvidkova J, Hána V, Marek J, Haluzík M, Lai EW, Pacák K. Increased lipolysis of subcutaneous abdominal adipose tissue and altered noradrenergic activity in patients with Cushing's syndrome: an in-vivo microdialysis study. Physiol Res. 2006; 55 421-428
- 32 Dwivedi Y, Pandey GN. Adrenal glucocorticoids modulate [3H] cyclic AMP binding to protein kinase A (PKA), cyclic AMP-dependent PKA activity, and protein levels of selective regulatory and catalytic sub-unit isoforms of PKA in rat brain. J Pharmacol Exp Ther. 2000; 294 103-116
- 33 Hunzicker-Dunn M, Scott JD, Carr DW. Regulation of expression of A-kinase anchoring proteins in rat granulosa cells. Biol Reprod. 1998; 58 1496-1502
Correspondence
M. Lundgren
Bldg 9A, 2nd floor
Umeå University Hospital
901 85 Umeå
Sweden
Phone: +46/90/785 35 24
Fax: +46/90/785 44 00
Email: magdalena.lundgren@medicin.umu.se